Cost analysis of HIV treatment and drug-related adverse events when fixed-dose combinations of antiretrovirals (FDCs) were stopped, versus continuation with FDCs

BACKGROUND: The lower sales price of generic lamivudine has caused healthcare administrators to consider abolishing fixed-dose antiretroviral combinations (FDCs) that contain lamivudine and emtricitabine. The alternative is to administer the individual components of the FDCs separately, thus incorpo...

Descripción completa

Detalles Bibliográficos
Autores principales: Homar, Francesc, Lozano, Virginia, Martínez-Gómez, Juan, Oyagüez, Itziar, Pareja, Antonio, Payeras, Antoni, Serrano, Joaquín, Carratalá, Carmen, Casado, Miguel Ángel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484113/
https://www.ncbi.nlm.nih.gov/pubmed/22943676
http://dx.doi.org/10.1186/2191-1991-2-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484113/
https://www.ncbi.nlm.nih.gov/pubmed/22943676
http://dx.doi.org/10.1186/2191-1991-2-16

Ejemplares similares